Stocks/BMI

BMI three-lens brief

Evidence-based stock research on BMI. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 07:00 ET
$112.09$158.71$187.05

Performance

1W
-3.1%
1M
+19.9%
3M
+21.7%
6M
—
YTD
—
1Y
—
3Y
—
5Y
—
BMI · Nightly brief
Watch

Outperforming SPY by 28.8pp over 30 days.

  • Outperforming SPY by 28.8pp over 30 days.

BMI closed at $158.71 (+0.72%) as of 2026-11-12. Market cap: $4.60B. P/E (trailing) 36.7. Price is above the 50-day MA and above the 200-day MA. Positives: outperforming SPY by 28.8pp over 30 days.. Last quarter: Revenue $235.94M, net income $35.90M, free cash flow $123.38M.

Market ✓· Fundamentals ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on BMI, not one.

A single reasoning model has blind spots it doesn’t know about. We examine BMI across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://www.clearpathinvest.app/embed/BMI"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath BMI brief"></iframe>